Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Proteomic Analysis of Morphologically Changed Tissues after Prolonged Dexamethasone Treatment.

Malkawi AK, Masood A, Shinwari Z, Jacob M, Benabdelkamel H, Matic G, Almuhanna F, Dasouki M, Alaiya AA, Rahman AMA.

Int J Mol Sci. 2019 Jun 26;20(13). pii: E3122. doi: 10.3390/ijms20133122.

2.

Antibody-drug conjugate T-DM1 treatment for HER2+ breast cancer induces ROR1 and confers resistance through activation of Hippo transcriptional coactivator YAP1.

Islam SS, Uddin M, Noman ASM, Akter H, Dity NJ, Basiruzzman M, Uddin F, Ahsan J, Annoor S, Alaiya AA, Al-Alwan M, Yeger H, Farhat WA.

EBioMedicine. 2019 May;43:211-224. doi: 10.1016/j.ebiom.2019.04.061. Epub 2019 May 10.

3.

An atypical pulmonary fibrosis is associated with co-inheritance of mutations in the calcium binding protein genes S100A3 and S100A13.

Al-Mutairy EA, Imtiaz FA, Khalid M, Al Qattan S, Saleh S, Mahmoud LM, Al-Saif MM, Al-Haj L, Al-Enazi A, AlJebreen AM, Mohammed SF, Mobeireek AF, Alkattan K, Chisti MA, Luzina IG, Al-Owain M, Weheba I, Abdelsayed AM, Ramzan K, Janssen LJ, Conca W, Alaiya A, Collison KS, Meyer BF, Atamas SP, Khabar KS, Hasday JD, Al-Mohanna F.

Eur Respir J. 2019 Jul 18;54(1). pii: 1802041. doi: 10.1183/13993003.02041-2018. Print 2019 Jul.

4.

Association of TATA box-binding protein-associated factor RNA polymerase I subunit C (TAF1C) with T2DM.

Abdulwahab RA, Allaith AAA, Shinwari Z, Alaiya A, Giha HA.

Gene. 2019 Jul 20;706:43-51. doi: 10.1016/j.gene.2019.04.076. Epub 2019 Apr 27.

PMID:
31039436
5.

LC‑MS/MS proteomic analysis revealed novel associations of 37 proteins with T2DM and notable upregulation of immunoglobulins.

Abdulwahab RA, Alaiya A, Shinwari Z, Allaith AAA, Giha HA.

Int J Mol Med. 2019 May;43(5):2118-2132. doi: 10.3892/ijmm.2019.4127. Epub 2019 Mar 8.

6.

PD-L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation.

Almozyan S, Colak D, Mansour F, Alaiya A, Al-Harazi O, Qattan A, Al-Mohanna F, Al-Alwan M, Ghebeh H.

Int J Cancer. 2017 Oct 1;141(7):1402-1412. doi: 10.1002/ijc.30834. Epub 2017 Jun 30.

7.

Integrated Left Ventricular Global Transcriptome and Proteome Profiling in Human End-Stage Dilated Cardiomyopathy.

Colak D, Alaiya AA, Kaya N, Muiya NP, AlHarazi O, Shinwari Z, Andres E, Dzimiri N.

PLoS One. 2016 Oct 6;11(10):e0162669. doi: 10.1371/journal.pone.0162669. eCollection 2016.

8.

Protein signatures as potential surrogate biomarkers for stratification and prediction of treatment response in chronic myeloid leukemia patients.

Alaiya AA, Aljurf M, Shinwari Z, Almohareb F, Malhan H, Alzahrani H, Owaidah T, Fox J, Alsharif F, Mohamed SY, Rasheed W, Aldawsari G, Hanbali A, Ahmed SO, Chaudhri N.

Int J Oncol. 2016 Sep;49(3):913-33. doi: 10.3892/ijo.2016.3618. Epub 2016 Jul 7.

9.

Recessive mutations in COL25A1 are a cause of congenital cranial dysinnervation disorder.

Shinwari JM, Khan A, Awad S, Shinwari Z, Alaiya A, Alanazi M, Tahir A, Poizat C, Al Tassan N.

Am J Hum Genet. 2015 Jan 8;96(1):147-52. doi: 10.1016/j.ajhg.2014.11.006. Epub 2014 Dec 11.

10.

The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females.

Al-Moghrabi N, Nofel A, Al-Yousef N, Madkhali S, Bin Amer SM, Alaiya A, Shinwari Z, Al-Tweigeri T, Karakas B, Tulbah A, Aboussekhra A.

BMC Cancer. 2014 Nov 17;14:830. doi: 10.1186/1471-2407-14-830.

11.

Proteomic analysis of Class IV lupus nephritis.

Alaiya A, Assad L, Alkhafaji D, Shinwari Z, Almana H, Shoukri M, Alkorbi L, Ibrahim HG, Abdelsalam MS, Skolnik E, Adra C, Albaqumi M.

Nephrol Dial Transplant. 2015 Jan;30(1):62-70. doi: 10.1093/ndt/gfu215. Epub 2014 Jun 9.

PMID:
24914093
12.

The selective cytotoxic anti-cancer properties and proteomic analysis of Trigonella Foenum-Graecum.

Alsemari A, Alkhodairy F, Aldakan A, Al-Mohanna M, Bahoush E, Shinwari Z, Alaiya A.

BMC Complement Altern Med. 2014 Mar 29;14:114. doi: 10.1186/1472-6882-14-114.

13.

Proteomic analysis of soft tissue tumor implants treated with a novel polybisphosphonate.

Alaiya A, Fox J, Bobis S, Matic G, Shinwari Z, Barhoush E, Márquez M, Nilsson S, Holmberg AR.

Cancer Genomics Proteomics. 2014 Jan-Feb;11(1):39-49.

PMID:
24633318
14.

Differential marker expression by cultures rich in mesenchymal stem cells.

Wetzig A, Alaiya A, Al-Alwan M, Pradez CB, Pulicat MS, Al-Mazrou A, Shinwari Z, Sleiman GM, Ghebeh H, Al-Humaidan H, Gaafar A, Kanaan I, Adra C.

BMC Cell Biol. 2013 Dec 5;14:54. doi: 10.1186/1471-2121-14-54.

15.

Protein expression changes in ovarian cancer during the transition from benign to malignant.

Waldemarson S, Krogh M, Alaiya A, Kirik U, Schedvins K, Auer G, Hansson KM, Ossola R, Aebersold R, Lee H, Malmström J, James P.

J Proteome Res. 2012 May 4;11(5):2876-89. doi: 10.1021/pr201258q. Epub 2012 Apr 17.

PMID:
22471520
16.

Recessive mutations in ELOVL4 cause ichthyosis, intellectual disability, and spastic quadriplegia.

Aldahmesh MA, Mohamed JY, Alkuraya HS, Verma IC, Puri RD, Alaiya AA, Rizzo WB, Alkuraya FS.

Am J Hum Genet. 2011 Dec 9;89(6):745-50. doi: 10.1016/j.ajhg.2011.10.011. Epub 2011 Nov 17.

17.

Proteomics-based signature for human benign prostate hyperplasia and prostate adenocarcinoma.

Alaiya AA, Al-Mohanna M, Aslam M, Shinwari Z, Al-Mansouri L, Al-Rodayan M, Al-Eid M, Ahmad I, Hanash K, Tulbah A, Bin Mahfooz A, Adra C.

Int J Oncol. 2011 Apr;38(4):1047-57. doi: 10.3892/ijo.2011.937. Epub 2011 Feb 8.

PMID:
21305254
18.

Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule.

Ghebeh H, Lehe C, Barhoush E, Al-Romaih K, Tulbah A, Al-Alwan M, Hendrayani SF, Manogaran P, Alaiya A, Al-Tweigeri T, Aboussekhra A, Dermime S.

Breast Cancer Res. 2010;12(4):R48. doi: 10.1186/bcr2605. Epub 2010 Jul 13.

19.

A novel HAX1 gene mutation in severe congenital neutropenia (SCN) associated with neurological manifestations.

Faiyaz-Ul-Haque M, Al-Jefri A, Al-Dayel F, Bhuiyan JA, Abalkhail HA, Al-Nounou R, Al-Abdullatif A, Pulicat MS, Gaafar A, Alaiya AA, Peltekova I, Zaidi SH.

Eur J Pediatr. 2010 Jun;169(6):661-6. doi: 10.1007/s00431-010-1150-6. Epub 2010 Feb 25.

PMID:
20182745
20.

A novel missense mutation in the HAX1 gene in severe congenital neutropenia patients (Kostmann disease).

Faiyaz-Ul-Haque M, Al-Jefri A, Abalkhail HA, Toulimat M, Al-Muallimi MA, Pulicat MS, Gaafar A, Alaiya AA, Al-Dayel F, Peltekova I, Zaidi SH.

Clin Genet. 2009 Dec;76(6):569-72. doi: 10.1111/j.1399-0004.2009.01244.x. Epub 2009 Oct 1. No abstract available.

PMID:
19796188
21.

Differential tissue-specific protein markers of vaginal carcinoma.

Hellman K, Alaiya AA, Becker S, Lomnytska M, Schedvins K, Steinberg W, Hellström AC, Andersson S, Hellman U, Auer G.

Br J Cancer. 2009 Apr 21;100(8):1303-14. doi: 10.1038/sj.bjc.6604975. Epub 2009 Mar 24.

22.

Serum efficacy biomarkers for oncology.

Linder S, Alaiya A.

Biomark Med. 2009 Feb;3(1):47-54. doi: 10.2217/17520363.3.1.47.

PMID:
20477495
23.

Breast carcinoma-associated fibroblasts and their counterparts display neoplastic-specific changes.

Hawsawi NM, Ghebeh H, Hendrayani SF, Tulbah A, Al-Eid M, Al-Tweigeri T, Ajarim D, Alaiya A, Dermime S, Aboussekhra A.

Cancer Res. 2008 Apr 15;68(8):2717-25. doi: 10.1158/0008-5472.CAN-08-0192.

24.

Undifferentiated pelvic adenocarcinomas: diagnostic potential of protein profiling and multivariate analysis.

Roblick UJ, Bader FG, Lenander C, Hellman U, Zimmermann K, Becker S, Ost A, Alaiya A, Bruch HP, Keller R, Mirow L, Franzén B, Ried T, Auer G, Habermann JK.

Int J Colorectal Dis. 2008 May;23(5):483-91. doi: 10.1007/s00384-008-0448-6. Epub 2008 Feb 22.

PMID:
18293003
25.

Large-scale proteomics analysis of human ovarian cancer for biomarkers.

Bengtsson S, Krogh M, Szigyarto CA, Uhlen M, Schedvins K, Silfverswärd C, Linder S, Auer G, Alaiya A, James P.

J Proteome Res. 2007 Apr;6(4):1440-50. Epub 2007 Feb 22.

PMID:
17315909
26.

Proteomic Analysis of a Human Prostate Cancer Cell Line after Incubation with a Novel Somatostatin14 Derivative.

Liu Z, Mrquez M, Nilsson S, Holmberg AR, Alaiya A.

Cancer Genomics Proteomics. 2005 Nov-Dec;2(6):347-352. Epub 2005 Nov 1.

27.

Clinical cancer proteomics: promises and pitfalls.

Alaiya A, Al-Mohanna M, Linder S.

J Proteome Res. 2005 Jul-Aug;4(4):1213-22. Review.

PMID:
16083271
28.

Proteome analysis of skin distinguishes acute guttate from chronic plaque psoriasis.

Carlén LM, Sánchez F, Bergman AC, Becker S, Hirschberg D, Franzén B, Coffey J, Jörnvall H, Auer G, Alaiya AA, Ståhle M.

J Invest Dermatol. 2005 Jan;124(1):63-9.

29.

Protein expression patterns in primary carcinoma of the vagina.

Hellman K, Alaiya AA, Schedvins K, Steinberg W, Hellström AC, Auer G.

Br J Cancer. 2004 Jul 19;91(2):319-26.

30.

Improved grading of breast adenocarcinomas based on genomic instability.

Kronenwett U, Huwendiek S, Ostring C, Portwood N, Roblick UJ, Pawitan Y, Alaiya A, Sennerstam R, Zetterberg A, Auer G.

Cancer Res. 2004 Feb 1;64(3):904-9.

31.
32.

Protein expression profiling in human lung, breast, bladder, renal, colorectal and ovarian cancers.

Alaiya AA, Roblick UJ, Franzén B, Bruch HP, Auer G.

J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Apr 5;787(1):207-22. Review. No abstract available.

PMID:
12659742
33.

Molecular classification of borderline ovarian tumors using hierarchical cluster analysis of protein expression profiles.

Alaiya AA, Franzén B, Hagman A, Dysvik B, Roblick UJ, Becker S, Moberger B, Auer G, Linder S.

Int J Cancer. 2002 Apr 20;98(6):895-9.

34.

Ulcerative colitis and colorectal carcinoma: DNA-profile, laminin-5 gamma2 chain and cyclin A expression as early markers for risk assessment.

Habermann J, Lenander C, Roblick UJ, Krüger S, Ludwig D, Alaiya A, Freitag S, Dümbgen L, Bruch HP, Stange E, Salo S, Tryggvason K, Auer G, Schimmelpenning H.

Scand J Gastroenterol. 2001 Jul;36(7):751-8.

PMID:
11444475
35.

Identification of proteins in human prostate tumor material by two-dimensional gel electrophoresis and mass spectrometry.

Alaiya AA, Oppermann M, Langridge J, Roblick U, Egevad L, Brindstedt S, Hellström M, Linder S, Bergman T, Jörnvall H, Auer G.

Cell Mol Life Sci. 2001 Feb;58(2):307-11.

PMID:
11289312
36.

Polypeptide expression in prostate hyperplasia and prostate adenocarcinoma.

Alaiya A, Roblick U, Egevad L, Carlsson A, Franzén B, Volz D, Huwendiek S, Linder S, Auer G.

Anal Cell Pathol. 2000;21(1):1-9.

37.
38.

Identification of foetal brain proteins by two-dimensional gel electrophoresis and mass spectrometry comparison of samples from individuals with or without chromosome 21 trisomy.

Oppermann M, Cols N, Nyman T, Helin J, Saarinen J, Byman I, Toran N, Alaiya AA, Bergman T, Kalkkinen N, Gonzàlez-Duarte R, Jörnvall H.

Eur J Biochem. 2000 Aug;267(15):4713-9.

39.

Classification of human ovarian tumors using multivariate data analysis of polypeptide expression patterns.

Alaiya AA, Franzén B, Hagman A, Silfverswärd C, Moberger B, Linder S, Auer G.

Int J Cancer. 2000 Jun 1;86(5):731-6.

40.

Cancer proteomics: from identification of novel markers to creation of artifical learning models for tumor classification.

Alaiya AA, Franzén B, Auer G, Linder S.

Electrophoresis. 2000 Apr;21(6):1210-7. Review.

PMID:
10786893
41.

Identification of gel-separated tumor marker proteins by mass spectrometry.

Bergman AC, Benjamin T, Alaiya A, Waltham M, Sakaguchi K, Franzén B, Linder S, Bergman T, Auer G, Appella E, Wirth PJ, Jörnvall H.

Electrophoresis. 2000 Feb;21(3):679-86.

PMID:
10726777
42.

Napsin A, a member of the aspartic protease family, is abundantly expressed in normal lung and kidney tissue and is expressed in lung adenocarcinomas.

Chuman Y, Bergman A, Ueno T, Saito S, Sakaguchi K, Alaiya AA, Franzén B, Bergman T, Arnott D, Auer G, Appella E, Jörnvall H, Linder S.

FEBS Lett. 1999 Nov 26;462(1-2):129-34.

43.

Two-dimensional gel analysis of protein expression in ovarian tumors shows a low degree of intratumoral heterogeneity.

Alaiya AA, Franzén B, Moberger B, Silfverswärd C, Linder S, Auer G.

Electrophoresis. 1999 Apr-May;20(4-5):1039-46.

PMID:
10344283
44.

Protein kinase-dependent overexpression of the nuclear protein pirin in c-JUN and RAS transformed fibroblasts.

Bergman AC, Alaiya AA, Wendler W, Binetruy B, Shoshan M, Sakaguchi K, Bergman T, Kronenwett U, Auer G, Appella E, Jörnvall H, Linder S.

Cell Mol Life Sci. 1999 Mar;55(3):467-71.

PMID:
10228560
45.

Phenotypic analysis of ovarian carcinoma: polypeptide expression in benign, borderline and malignant tumors.

Alaiya AA, Franzén B, Fujioka K, Moberger B, Schedvins K, Silfversvärd C, Linder S, Auer G.

Int J Cancer. 1997 Nov 27;73(5):678-83.

46.

Increased expression of alpha-enolase in c-jun transformed rat fibroblasts without increased activation of plasminogen.

Bergman AC, Linder C, Sakaguchi K, Sten-Linder M, Alaiya AA, Franzén B, Shoshan MC, Bergman T, Wiman B, Auer G, Appella E, Jörnvall H, Linder S.

FEBS Lett. 1997 Nov 3;417(1):17-20.

47.

Biophysical and physiological properties of a modified porcine surfactant enriched with surfactant protein A.

Sun B, Curstedt T, Lindgren G, Franzén B, Alaiya AA, Calkovská A, Robertson B.

Eur Respir J. 1997 Sep;10(9):1967-74.

48.

Analysis of polypeptide expression in benign and malignant human breast lesions.

Franzén B, Linder S, Alaiya AA, Eriksson E, Fujioka K, Bergman AC, Jörnvall H, Auer G.

Electrophoresis. 1997 Mar-Apr;18(3-4):582-7.

PMID:
9150945
49.

Analysis of polypeptide expression in benign and malignant human breast lesions: down-regulation of cytokeratins.

Franzén B, Linder S, Alaiya AA, Eriksson E, Uruy K, Hirano T, Okuzawa K, Auer G.

Br J Cancer. 1996 Nov;74(10):1632-8.

50.

Assessment of homogeneity in polypeptide expression in breast carcinomas shows widely variable expression in highly malignant tumors.

Franzén B, Auer G, Alaiya AA, Eriksson E, Uryu K, Hirano T, Okuzawa K, Kato H, Linder S.

Int J Cancer. 1996 Oct 21;69(5):408-14.

Supplemental Content

Loading ...
Support Center